background
background
Earnings Expectation?
Beat
Meet
Miss
Expected Price Action?
Up
Flat
Down
Thursday
May 29, 2025
7:00 AM ET
Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025
Tuesday
March 18, 2025
4:32 PM ET
Immunovant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Programs
Thursday
February 6, 2025
6:30 AM ET
Immunovant Reports Financial Results for the Quarter Ended December 31, 2024